-
1
-
-
0030760531
-
Methylphenidate
-
Prescrire Editorial Staff
-
Prescrire Editorial Staff "Methylphenidate Prescrire Int 1997; 6 (31): 126-130.
-
(1997)
Prescrire Int
, vol.6
, Issue.31
, pp. 126-130
-
-
-
2
-
-
70350674931
-
Hyperactivité avec déficit de l'attention: Gare au dérapage (suite). Le méthylphénidate n'est qu'un recours
-
Prescrire Rédaction
-
Prescrire Rédaction "Hyperactivité avec déficit de l'attention: gare au dérapage (suite). Le méthylphé nidate n'est qu'un recours" Rev Prescrire 2004; 24 (249): 289-291.
-
(2004)
Rev Prescrire
, vol.24
, Issue.249
, pp. 289-291
-
-
-
3
-
-
80053533031
-
Hallucinations induites par le méthylphénidate
-
Prescrire Rédaction
-
Prescrire Rédaction "Hallucinations induites par le méthylphénidate" Rev Prescrire 2006; 26 (275): 590-591.
-
(2006)
Rev Prescrire
, vol.26
, Issue.275
, pp. 590-591
-
-
-
4
-
-
23144464946
-
Growth on stimulant medication; clarifying the confusion: A review
-
Poulton A "Growth on stimulant medication; clarifying the confusion: a review" Arch Dis Child 2005; 90: 801-806.
-
(2005)
Arch Dis Child
, vol.90
, pp. 801-806
-
-
Poulton, A.1
-
5
-
-
0032753828
-
A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder
-
The MTA Cooperative Group
-
The MTA Cooperative Group "A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder" Arch Gen Psychiatry 1999; 56: 1073-1086.
-
(1999)
Arch Gen Psychiatry
, vol.56
, pp. 1073-1086
-
-
-
6
-
-
1842586516
-
National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: Changes in effectiveness and growth after the end of treatment
-
The MTA Cooperative Group
-
The MTA Cooperative Group "National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment" Pediatrics 2004; 113 (4): 762-769.
-
(2004)
Pediatrics
, vol.113
, Issue.4
, pp. 762-769
-
-
-
7
-
-
34547671938
-
Effects of stimulant medication on growth rates across 3 years in the MTA follow-up
-
Swanson JM et al. "Effects of stimulant medication on growth rates across 3 years in the MTA follow-up" J Am Acad Child Adolesc Psychiatry 2007; 46 (8): 1015-1027.
-
(2007)
J Am Acad Child Adolesc Psychiatry
, vol.46
, Issue.8
, pp. 1015-1027
-
-
Swanson, J.M.1
-
8
-
-
80053540732
-
-
Agence française de sécurité sanitaire des produits de santé 30 October 2009. afssaps.sante.fr accessed 22 September
-
Agence française de sécurité sanitaire des produits de santé "Résumé des caractéristiques du produit - Ritaline 10 mg" 30 October 2009. afssaps.sante.fr accessed 22 September 2010: 9 pages.
-
(2010)
Résumé des Caractéristiques du Produit - Ritaline 10 Mg
, pp. 9
-
-
-
9
-
-
33646378149
-
Stimulant treatment over 5 years: Effects on growth
-
Charach A et al. "Stimulant treatment over 5 years: effects on growth" J Am Acad Child Adolesc Psychiatry 2006; 45 (4): 415-421.
-
(2006)
J Am Acad Child Adolesc Psychiatry
, vol.45
, Issue.4
, pp. 415-421
-
-
Charach, A.1
-
10
-
-
77956252632
-
Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD
-
Zhang H et al. "Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD" Neuropediatrics 2010; 41 (2): 55-59.
-
(2010)
Neuropediatrics
, vol.41
, Issue.2
, pp. 55-59
-
-
Zhang, H.1
-
11
-
-
84925548399
-
A naturalistic 10-year prospective study of height and weight in children with Attention-Deficit Hyperactivity Disorder Grown Up: Sex and Treatment Effects
-
Biederman J et al. "A naturalistic 10-year prospective study of height and weight in children with Attention-Deficit Hyperactivity Disorder Grown Up: Sex and Treatment Effects" J Pediatr 2010; 157: 635-640.
-
(2010)
J Pediatr
, vol.157
, pp. 635-640
-
-
Biederman, J.1
-
12
-
-
31844444642
-
Effects of long-term psychostimulant medication on growth of children with ADHD
-
Zachor DA et al. "Effects of long-term psychostimulant medication on growth of children with ADHD" Res Dev Disabil 2006; 27 (2): 162-174.
-
(2006)
Res Dev Disabil
, vol.27
, Issue.2
, pp. 162-174
-
-
Zachor, D.A.1
-
13
-
-
55749096764
-
Effect of stimulants on height and weight: A review of the literature
-
Faraone SV et al. "Effect of stimulants on height and weight: a review of the literature" J Am Acad Child Adolesc Psychiatry 2008; 47 (9): 994-1009.
-
(2008)
J Am Acad Child Adolesc Psychiatry
, vol.47
, Issue.9
, pp. 994-1009
-
-
Faraone, S.V.1
-
14
-
-
80053540245
-
L'amphétamine: Principaux effets, désirables ou non
-
Prescrire Rédaction
-
Prescrire Rédaction "L'amphétamine: principaux effets, désirables ou non" Rev Prescrire 2003; 23 (243): 674-675.
-
(2003)
Rev Prescrire
, vol.23
, Issue.243
, pp. 674-675
-
-
-
15
-
-
39149117391
-
Understanding the risk of using medications for ADHD with respect to physical growth and cardiovascular function
-
Vitiello B "Understanding the risk of using medications for ADHD with respect to physical growth and cardiovascular function" Child Adolesc Psychiatry Clin N Am 2008; 17 (2): 459-471.
-
(2008)
Child Adolesc Psychiatry Clin N Am
, vol.17
, Issue.2
, pp. 459-471
-
-
Vitiello, B.1
-
16
-
-
80053525911
-
Methylphenidate
-
The Pharmaceutical Press, London. accessed 4 January
-
"Methylphenidate". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 4 January 2010: 11 pages.
-
(2010)
Martindale the Complete Drug Reference
, pp. 11
-
-
-
17
-
-
80053506206
-
Dexamfetamine sulfate
-
The Pharmaceutical Press, London. accessed 4 January
-
"Dexamfetamine sulfate". In: "Martindale The Complete Drug Reference" The Pharmaceutical Press, London. www.medicinescomplete.com accessed 4 January 2010: 10 pages.
-
(2010)
Martindale the Complete Drug Reference
, pp. 10
-
-
-
18
-
-
33846112042
-
Treatment of attention deficit hyperactivity disorder in children and adolescents - Safety considerations
-
Wolraich ML et al. "Treatment of attention deficit hyperactivity disorder in children and adolescents - Safety considerations" Drug Saf 2007; 30 (1): 1726.
-
(2007)
Drug Saf
, vol.30
, Issue.1
, pp. 1726
-
-
Wolraich, M.L.1
|